SynthesisAbdominal radiology (New York)2024

Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.

Shuwei Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.